secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2024-09-11T23:59:59+00:00
Accession:  0001213900-24-077457
Event type: leadership
Sentiment:  neutral
Materiality: 0.80
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix shareholders elect directors and approve reverse stock split, equity plan amendments
--------------------------------------------------------------------------------

- Timothy Ramdeen and Ajit Singh were elected as Class III directors with 6,238,121 and 6,368,501 votes for, respectively.
- Approved reverse stock split at ratio between 1:30 and 1:60, with 12,403,389 votes for.
- Approved 2022 Equity Incentive Plan amendment increasing authorized shares by 54,850,000 (58,000,000 total), 4,956,245 votes for.
- Approved issuance of up to 5,709,935 shares upon Series A conversion and 269,672,900 shares upon Series B conversion.
- Ratified EisnerAmper LLP as independent auditor for FY2024 with 13,323,616 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390024077457/0001213900-24-077457-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390024077457/ea0214181-8k_onconetix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-077457

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer